商標ウォッチ

TOP｜特許｜意匠｜商標

商標ウォッチ Twitter

公開日2025-02-05
公報種別公開国際商標公報
国際登録番号1824729
国際登録日2024-08-06
区分第5類(薬剤),第10類(医用機器)
商品役務Injectable pharmaceutical preparations comprising erodible ingredients that facilitate the delivery of pharmaceuticals via injection into the posterior segment of the eye for the treatment of eye diseases and conditions of the retina, namely, wet age-related macular degeneration, non-proliferative diabetic retinopathy, diabetic macular edema and retinal vein occlusion and excluding dry eye, conjunctivitis, glaucoma and bacterial eye infections.,Injectable sustained drug delivery systems for delivering pharmaceuticals via injection into the posterior segment of the eye.
基礎出願番号97858204,98677791
基礎出願日2023-03-27,2024-08-01
基礎出願国US,US
出願人EyePoint Pharmaceuticals US, Inc.
OCRテキストDURASERT E
OCRテキスト2
OCRについて

この商標をJ-PlatPatで参照する

関連商標

Tourmaline Bio, Inc.

Osanni Bio, Inc.

MASTELLI S.R.L.

Freeline Therapeutics Limited

Incyte Holdings Corporation

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

Population Health Partners, L.P.

Roogenic Pty Ltd

Straumann Holding AG

MediBeacon Inc.

DayOne Performance GmbH

IDEAS OCEAN COMPANY LIMITED

Boegli-Gravures SA

Glanbia Nutritionals Limited

CAPTURE COLLECTIVE, INC.

続きを見る